PTPN11 and neoplasm: Furthermore, treatment of mice with the Shp2 inhibitor, SHP099, reduced the number of metastatic nodules and the overall tumour mass in the lung (P = 0.3622) (Fig. 8g and quantified in Fig. 8h).